Most cited papers in Adrenal and Paraganglionic Tumors
What are the most cited papers in Adrenal and Paraganglionic Tumors?
The most cited paper in Adrenal and Paraganglionic Tumors is "1994 Consensus Conference on Acute GVHD Grading." (Donna Przepiorka, Daniel Weisdorf, Peyton Martin et al., 1995), with 5,088 citations. Next come "Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway" (3,308) and "The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline" (2,957).
Showing 50 of 100 papers. Every paper with more than 597 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | 1994 Consensus Conference on Acute GVHD Grading. Donna Przepiorka, Daniel Weisdorf, Peyton Martin et al. · PubMed | Jun 1995 | 5,088 |
| 2 | Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway William G. Kaelin, Peter John Ratcliffe · Molecular Cell | May 2008 | 3,308 |
| 3 | The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline John W. Funder, Robert M. Carey, Franco Mantero et al. · The Journal of Clinical Endocrinology & Metabolism | 2 Mar 2016 | 2,957 |
| 4 | Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline Jacques W.M. Lenders, Quan‐Yang Duh, Graeme Eisenhofer et al. · The Journal of Clinical Endocrinology & Metabolism | Jun 2014 | 2,828 |
| 5 | The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline Lynnette K. Nieman, Beverly M. K. Biller, James W. Findling et al. · The Journal of Clinical Endocrinology & Metabolism | 11 Mar 2008 | 2,727 |
| 6 | Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase Mary A. Selak, Sean M. Armour, Elaine D. MacKenzie et al. · Cancer Cell | 2005 | 2,120 |
| 7 | Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline Shlomo K. Melmed, Felipe F. Casanueva, Andrew R. Hoffman et al. · The Journal of Clinical Endocrinology & Metabolism | Feb 2011 | 1,858 |
| 8 | Cushing's syndrome André Lacroix, Richard Abraham Feelders, Constantine A. Stratakis et al. · The Lancet | 21 May 2015 | 1,764 |
| 9 | Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma Bora E. Baysal, Robert E. Ferrell, Joan E. Willett-Brozick et al. · Science | 4 Feb 2000 | 1,652 |
| 10 | von Hippel-Lindau disease Russell R. Lonser, Gladys M. Glenn, McClellan M. Walther et al. · The Lancet | Jun 2003 | 1,616 |
| 11 | Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors Martin Faßnacht, Wiebke Arlt, Irina Bancos et al. · European Journal of Endocrinology | 7 Jul 2016 | 1,572 |
| 12 | Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline John W. Funder, Robert M. Carey, Carlos Fardella et al. · The Journal of Clinical Endocrinology & Metabolism | 13 Jun 2008 | 1,557 |
| 13 | Phaeochromocytoma Jacques W.M. Lenders, Graeme Eisenhofer, Massimo Mannelli et al. · The Lancet | Aug 2005 | 1,529 |
| 14 | Germ-Line Mutations in Nonsyndromic Pheochromocytoma Hartmut P.H. Neumann et al. · New England Journal of Medicine | 9 May 2002 | 1,373 |
| 15 | Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management Annamaria Anita Livia Colao, Diego Ferone, Paolo Marzullo et al. · Endocrine Reviews | Feb 2004 | 1,319 |
| 16 | Malignant peripheral nerve sheath tumours in neurofibromatosis 1 D. Gareth Evans, M E Baser, J McGaughran et al. · Journal of Medical Genetics | May 2002 | 1,297 |
| 17 | Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline Lynnette K. Nieman, Beverly M. K. Biller, James W. Findling et al. · The Journal of Clinical Endocrinology & Metabolism | 29 Jul 2015 | 1,276 |
| 18 | Cushing's syndrome John D C Newell-Price, XAVIER Y. BERTAGNA, Ashley Barry Grossman et al. · The Lancet | May 2006 | 1,171 |
| 19 | Acromegaly Shlomo K. Melmed · New England Journal of Medicine | 13 Dec 2006 | 1,158 |
| 20 | Biochemical Diagnosis of Pheochromocytoma Jacques W.M. Lenders, Karel Pacák, McClellan M. Walther et al. · JAMA | 20 Mar 2002 | 1,142 |
| 21 | The Complex of Myxomas, Spotty Pigmentation, and Endocrine Overactivity J. Aidan Carney, Hymie Gordon, Paul C. Carpenter et al. · Medicine | Jul 1985 | 1,129 |
| 22 | The Incidentally Discovered Adrenal Mass William F. Young · New England Journal of Medicine | 7 Feb 2007 | 1,105 |
| 23 | Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma Dewi Astuti, Farida Latif, Ashraf Dallol et al. · The American Journal of Human Genetics | Jul 2001 | 1,101 |
| 24 | The International Neuroblastoma Pathology Classification (the Shimada system) Hiroyuki Shimada, Inge M. Ambros, Louis P. Dehner et al. · Cancer | 15 Jul 1999 | 1,042 |
| 25 | 68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT Michael Gabriel, Clemens Decristoforo, Dorota Kendler et al. · Journal of Nuclear Medicine | Apr 2007 | 1,016 |
| 26 | Association between premature mortality and hypopituitarism Jeremy Tomlinson, N Holden, Robert K. Hills et al. · The Lancet | Feb 2001 | 1,011 |
| 27 | K + Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension Murim Choi, Ute I. Scholl, Peng Yue et al. · Science | 10 Feb 2011 | 1,003 |
| 28 | Criteria for Cure of Acromegaly: A Consensus Statement Andrea Giustina · The Journal of Clinical Endocrinology & Metabolism | Feb 2000 | 996 |
| 29 | Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort Tracy Ann Williams et al. · The Lancet Diabetes & Endocrinology | 31 May 2017 | 978 |
| 30 | 11β-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response Jeremy Tomlinson, Elizabeth A. Walker, Iwona J. Bujalska et al. · Endocrine Reviews | Oct 2004 | 976 |
| 31 | European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors Martin Faßnacht, Olaf M Dekkers, Tobias Else et al. · European Journal of Endocrinology | 24 Jul 2018 | 970 |
| 32 | Increased Diagnosis of Primary Aldosteronism, Including Surgically Correctable Forms, in Centers from Five Continents Paolo Mulatero, Michael Stowasser, Keh‐Chuan Loh et al. · The Journal of Clinical Endocrinology & Metabolism | Mar 2004 | 964 |
| 33 | HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability Jennifer S. Isaacs, Yun Jin Jung, David Robert Mole et al. · Cancer Cell | Aug 2005 | 959 |
| 34 | Management of the Clinically Inapparent Adrenal Mass (Incidentaloma) Melvin M. Grumbach, Beverly M.K. Biller, Glenn D. Braunstein et al. · Annals of Internal Medicine | 4 Mar 2003 | 957 |
| 35 | Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell Carcinoma Raju R. Raval, Kah Weng Lau, Maxine G B Tran et al. · Molecular and Cellular Biology | 16 Jun 2005 | 948 |
| 36 | Distinct Clinical Features of Paraganglioma Syndromes Associated With SDHB and SDHD Gene Mutations Hartmut P.H. Neumann · JAMA | 24 Aug 2004 | 908 |
| 37 | Adrenocortical Carcinoma Tobias Else, Alex C. Kim, Aaron N. Sabolch et al. · Endocrine Reviews | 20 Dec 2013 | 905 |
| 38 | A Survey of Childhood Malignancies ALICE M. STEWART, J.W. Webb, D. Hewitt · BMJ | 28 Jun 1958 | 892 |
| 39 | Mutations in SDHC cause autosomal dominant paraganglioma, type 3 Stephan Niemann, Ulrich Müller · Nature Genetics | Nov 2000 | 885 |
| 40 | Combination Chemotherapy in Advanced Adrenocortical Carcinoma Martin Faßnacht et al. · New England Journal of Medicine | 2 May 2012 | 881 |
| 41 | Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations Patrick J. Pollard et al. · Human Molecular Genetics | 29 Jun 2005 | 867 |
| 42 | Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement Beverly M. K. Biller et al. · The Journal of Clinical Endocrinology & Metabolism | 15 Apr 2008 | 864 |
| 43 | Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas Felipe F. Casanueva, Mark E. Molitch, Janet Schlechte et al. · Clinical Endocrinology | 8 Jun 2006 | 833 |
| 44 | Incidentally Discovered Adrenal Masses* Richard T. Kloos, Milton D. Gross, Isaac R. Francis et al. · Endocrine Reviews | Aug 1995 | 833 |
| 45 | Advances in the Treatment of Prolactinomas Mary P. Gillam, Mark E. Molitch, Gaetano Lombardi et al. · Endocrine Reviews | 26 May 2006 | 831 |
| 46 | Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells Ryo Fukuda, Kiichi Hirota, Fan Fan et al. · Journal of Biological Chemistry | Oct 2002 | 824 |
| 47 | Pathologic Features of Prognostic Significance in Adrenocortical Carcinoma Lawrence Martin Weiss, L. Jeffrey Medeiros, Austin L. Vickery · The American Journal of Surgical Pathology | Mar 1989 | 824 |
| 48 | Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization Massimiliano Mazzone et al. · Cell | 13 Feb 2009 | 818 |
| 49 | Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan Kazuya Kondo, Yasumasa Monden · The Annals of Thoracic Surgery | Sep 2003 | 811 |
| 50 | Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma Lauren Michelle Fishbein et al. · Cancer Cell | Feb 2017 | 807 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.